Cross-sectional study of health impairment related to post COVID-19 condition among participants of a large population-based cohort in Germany.

Diexer, Sophie; Kaaks, Rudolf; Meinke-Franze, Claudia; Rübsamen, Nicole; Keil, Thomas; Fricke, Julia; Lieb, Wolfgang; Klett-Tammen, Carolina J; Karch, André; Obi, Nadia; Michels, Karin B; Pfrommer, Laura R; Thierry, Sigrid; Peters, Annette; Velásquez, Ilais Moreno; Frost, Jonas; Pischon, Tobias; Mikolajczyk, Rafael; Wright, Marvin N; Schmidt, Börge; Brenner, Hermann; Leitzmann, Michael F; Heise, Jana-Kristin; Harth, Volker; Purschke, Oliver; Gabrysch, Sabine; Greiser, Karin-Halina; Klee, Bianca; Baernighausen, Till W; Völzke, Henry; Lampl, Benedikt M J; Zeeb, Hajo; Ahnert, Peter; Krist, Lilian; Schikowski, Tamara

doi:10.1038/s41598-025-07894-7

Items
Marc 21

001			303023
005			20250722114136.0
024	7	_	\|a 10.1038/s41598-025-07894-7 \|2 doi
024	7	_	\|a pmid:40670423 \|2 pmid
024	7	_	\|a pmc:PMC12267414 \|2 pmc
037	_	_	\|a DKFZ-2025-01470
041	_	_	\|a English
082	_	_	\|a 600
100	1	_	\|a Diexer, Sophie \|b 0
245	_	_	\|a Cross-sectional study of health impairment related to post COVID-19 condition among participants of a large population-based cohort in Germany.
260	_	_	\|a [London] \|c 2025 \|b Springer Nature
336	7	_	\|a article \|2 DRIVER
336	7	_	\|a Output Types/Journal article \|2 DataCite
336	7	_	\|a Journal Article \|b journal \|m journal \|0 PUB:(DE-HGF)16 \|s 1753097959_5173 \|2 PUB:(DE-HGF)
336	7	_	\|a ARTICLE \|2 BibTeX
336	7	_	\|a JOURNAL_ARTICLE \|2 ORCID
336	7	_	\|a Journal Article \|0 0 \|2 EndNote
520	_	_	\|a Post COVID-19 condition (PCC) is a substantial burden for patients, society, and the healthcare system. Participants of the German National Cohort (NAKO) were asked in an online survey about their self-perceived health, symptoms related to PCC, and infection status. PCC was defined as reporting symptoms for the time window 4-12 months after infection. Of 110,375 respondents (73% response), 86,833 were included in this analysis. Of these, 44,451 (51%) did not report a SARS-CoV-2 infection (no infection), 26,726 (31%) reported an infection but no symptoms 4-12 months after infection (infection/no PCC), and 15,656 (18%) reported an infection and symptoms (PCC). The median number of current symptoms at the time of the survey was two for the 'no infection' and the 'infection/no PCC' group, and five for the 'PCC' group. Participants with PCC had a substantially higher probability of having worse self-perceived health (OR 1.84, 95% CI [1.75; 1.93] compared to the 'no infection' group, adjusting for sex, age, education and chronic diseases with elevated risk for developing PCC. After adjusting for the number of current symptoms related to PCC, this difference disappeared, suggesting that the symptoms collected explain the impairment of self-perceived health in the PCC group.
536	_	_	\|a 313 - Krebsrisikofaktoren und Prävention (POF4-313) \|0 G:(DE-HGF)POF4-313 \|c POF4-313 \|f POF IV \|x 0
588	_	_	\|a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650	_	2	\|a Humans \|2 MeSH
650	_	2	\|a COVID-19: epidemiology \|2 MeSH
650	_	2	\|a COVID-19: complications \|2 MeSH
650	_	2	\|a Germany: epidemiology \|2 MeSH
650	_	2	\|a Female \|2 MeSH
650	_	2	\|a Male \|2 MeSH
650	_	2	\|a Middle Aged \|2 MeSH
650	_	2	\|a Cross-Sectional Studies \|2 MeSH
650	_	2	\|a Adult \|2 MeSH
650	_	2	\|a Aged \|2 MeSH
650	_	2	\|a SARS-CoV-2: isolation & purification \|2 MeSH
650	_	2	\|a Surveys and Questionnaires \|2 MeSH
650	_	2	\|a Health Status \|2 MeSH
650	_	2	\|a Cohort Studies \|2 MeSH
650	_	2	\|a Post-Acute COVID-19 Syndrome \|2 MeSH
700	1	_	\|a Frost, Jonas \|b 1
700	1	_	\|a Ahnert, Peter \|b 2
700	1	_	\|a Baernighausen, Till W \|b 3
700	1	_	\|a Brenner, Hermann \|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2 \|b 4 \|u dkfz
700	1	_	\|a Fricke, Julia \|b 5
700	1	_	\|a Gabrysch, Sabine \|b 6
700	1	_	\|a Greiser, Karin-Halina \|0 P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b \|b 7 \|u dkfz
700	1	_	\|a Harth, Volker \|b 8
700	1	_	\|a Heise, Jana-Kristin \|b 9
700	1	_	\|a Kaaks, Rudolf \|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a \|b 10 \|u dkfz
700	1	_	\|a Karch, André \|b 11
700	1	_	\|a Keil, Thomas \|b 12
700	1	_	\|a Klee, Bianca \|b 13
700	1	_	\|a Klett-Tammen, Carolina J \|b 14
700	1	_	\|a Krist, Lilian \|b 15
700	1	_	\|a Lampl, Benedikt M J \|b 16
700	1	_	\|a Leitzmann, Michael F \|b 17
700	1	_	\|a Lieb, Wolfgang \|b 18
700	1	_	\|a Meinke-Franze, Claudia \|b 19
700	1	_	\|a Michels, Karin B \|b 20
700	1	_	\|a Velásquez, Ilais Moreno \|b 21
700	1	_	\|a Obi, Nadia \|b 22
700	1	_	\|a Peters, Annette \|b 23
700	1	_	\|a Pfrommer, Laura R \|b 24
700	1	_	\|a Pischon, Tobias \|b 25
700	1	_	\|a Purschke, Oliver \|b 26
700	1	_	\|a Rübsamen, Nicole \|b 27
700	1	_	\|a Schikowski, Tamara \|b 28
700	1	_	\|a Schmidt, Börge \|b 29
700	1	_	\|a Thierry, Sigrid \|b 30
700	1	_	\|a Völzke, Henry \|b 31
700	1	_	\|a Wright, Marvin N \|b 32
700	1	_	\|a Zeeb, Hajo \|b 33
700	1	_	\|a Mikolajczyk, Rafael \|b 34
773	_	_	\|a 10.1038/s41598-025-07894-7 \|g Vol. 15, no. 1, p. 25830 \|0 PERI:(DE-600)2615211-3 \|n 1 \|p 25830 \|t Scientific reports \|v 15 \|y 2025 \|x 2045-2322
909	C	O	\|o oai:inrepo02.dkfz.de:303023 \|p VDB
910	1	_	\|a Deutsches Krebsforschungszentrum \|0 I:(DE-588b)2036810-0 \|k DKFZ \|b 4 \|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910	1	_	\|a Deutsches Krebsforschungszentrum \|0 I:(DE-588b)2036810-0 \|k DKFZ \|b 7 \|6 P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b
910	1	_	\|a Deutsches Krebsforschungszentrum \|0 I:(DE-588b)2036810-0 \|k DKFZ \|b 10 \|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
913	1	_	\|a DE-HGF \|b Gesundheit \|l Krebsforschung \|1 G:(DE-HGF)POF4-310 \|0 G:(DE-HGF)POF4-313 \|3 G:(DE-HGF)POF4 \|2 G:(DE-HGF)POF4-300 \|4 G:(DE-HGF)POF \|v Krebsrisikofaktoren und Prävention \|x 0
914	1	_	\|y 2025
915	_	_	\|a JCR \|0 StatID:(DE-HGF)0100 \|2 StatID \|b SCI REP-UK : 2022 \|d 2024-12-18
915	_	_	\|a DBCoverage \|0 StatID:(DE-HGF)0200 \|2 StatID \|b SCOPUS \|d 2024-12-18
915	_	_	\|a DBCoverage \|0 StatID:(DE-HGF)0300 \|2 StatID \|b Medline \|d 2024-12-18
915	_	_	\|a DBCoverage \|0 StatID:(DE-HGF)0501 \|2 StatID \|b DOAJ Seal \|d 2024-07-29T15:28:26Z
915	_	_	\|a DBCoverage \|0 StatID:(DE-HGF)0500 \|2 StatID \|b DOAJ \|d 2024-07-29T15:28:26Z
915	_	_	\|a Peer Review \|0 StatID:(DE-HGF)0030 \|2 StatID \|b DOAJ : Anonymous peer review \|d 2024-07-29T15:28:26Z
915	_	_	\|a DBCoverage \|0 StatID:(DE-HGF)0600 \|2 StatID \|b Ebsco Academic Search \|d 2024-12-18
915	_	_	\|a Peer Review \|0 StatID:(DE-HGF)0030 \|2 StatID \|b ASC \|d 2024-12-18
915	_	_	\|a DBCoverage \|0 StatID:(DE-HGF)0199 \|2 StatID \|b Clarivate Analytics Master Journal List \|d 2024-12-18
915	_	_	\|a DBCoverage \|0 StatID:(DE-HGF)1040 \|2 StatID \|b Zoological Record \|d 2024-12-18
915	_	_	\|a DBCoverage \|0 StatID:(DE-HGF)1150 \|2 StatID \|b Current Contents - Physical, Chemical and Earth Sciences \|d 2024-12-18
915	_	_	\|a DBCoverage \|0 StatID:(DE-HGF)1050 \|2 StatID \|b BIOSIS Previews \|d 2024-12-18
915	_	_	\|a DBCoverage \|0 StatID:(DE-HGF)0160 \|2 StatID \|b Essential Science Indicators \|d 2024-12-18
915	_	_	\|a DBCoverage \|0 StatID:(DE-HGF)1190 \|2 StatID \|b Biological Abstracts \|d 2024-12-18
915	_	_	\|a WoS \|0 StatID:(DE-HGF)0113 \|2 StatID \|b Science Citation Index Expanded \|d 2024-12-18
915	_	_	\|a DBCoverage \|0 StatID:(DE-HGF)0150 \|2 StatID \|b Web of Science Core Collection \|d 2024-12-18
915	_	_	\|a IF < 5 \|0 StatID:(DE-HGF)9900 \|2 StatID \|d 2024-12-18
915	_	_	\|a Article Processing Charges \|0 StatID:(DE-HGF)0561 \|2 StatID \|d 2024-12-18
915	_	_	\|a Fees \|0 StatID:(DE-HGF)0700 \|2 StatID \|d 2024-12-18
920	1	_	\|0 I:(DE-He78)C020-20160331 \|k C020 \|l Epidemiologie von Krebs \|x 0
920	1	_	\|0 I:(DE-He78)C070-20160331 \|k C070 \|l C070 Klinische Epidemiologie der Krebsfrüherkennung \|x 1
980	_	_	\|a journal
980	_	_	\|a VDB
980	_	_	\|a I:(DE-He78)C020-20160331
980	_	_	\|a I:(DE-He78)C070-20160331
980	_	_	\|a UNRESTRICTED

Library	Collection	CLSMajor	CLSMinor	Language	Author

Marc 21

guest :: login DKFZ
		Search		Submit		Personalize Your alerts Your baskets Your searches		Help